Unresectable Salivary Gland Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-03
Clinical Trial Update: Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers [Phase 2]
Phase 2 trial evaluating ado-trastuzumab emtansine versus standard chemotherapy with docetaxel plus trastuzumab or trastuzumab deruxtecan in…
CLINICAL_TRIALS trial_result · 2025-11-10
Clinical Trial Update: Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers [Phase 2]
A Phase 2 trial evaluating darolutamide for testosterone-driven salivary gland cancers is active but not currently recruiting. The study enc…